Related Experiment Video
Updated: May 12, 2026

Temporomandibular Joint Pain Measurement by Bite Force and Von Frey Filament Assays in Mice
Published on: September 13, 2024
Pain and temporomandibular disorders: a pharmaco-gender dilemma
Jeffry R Shaefer1, Nicole Holland, Julia S Whelan
1Department of Oral and Maxillofacial Surgery, Harvard School of Dental Medicine, Boston, MA 02215, USA. jeffry_shaefer@hsdm.harvard.edu
Abstract:
Gender is the biggest risk factor in the development of temporomandibular disorders (TMD) and orofacial pain. Gender differences in pain thresholds, temporal summation, pain expectations, and somatic awareness exist in patients with chronic TMD or orofacial pain. There are gender differences in pharmacokenetics and pharmacodynamics of medications used to treat pain. A better understanding of the mechanisms that contribute to the increased incidence and persistence of chronic pain in females is needed. Future research will elucidate the sex effects on factors that protect against developing pain or prevent debilitating pain. Gender-based treatments for TMD and orofacial pain treatment will evolve from the translational research stimulated by this knowledge.
Related Concept Videos
Panic Disorder
Analgesia and Pain Management
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Therapeutic Drug Monitoring: Affecting Factors

